Dose-Finding Study of Intranasal Insulin in Healthy Participants Insulin in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

October 4, 2021

Primary Completion Date

April 25, 2022

Study Completion Date

April 25, 2022

Conditions
Out-Of-Hospital Cardiac ArrestHealthy
Interventions
DRUG

Intranasal insulin

"This will be given intranasally at differing doses depending on study day. A total of 11 possible doses will be tested, ranging from 0 to 1000 U insulin. Each volunteer will come for 5 visits.~On the first treatment day participants will receive placebo (sterile water) in each nostril followed by a 4-hour observation period. After this observation period participants will receive the initial dose of insulin squirted in each nostril followed by a a 4 hour observation period. Participants will have at least 7 days in between the other 4 visits. Subsequent visits will include increased doses of insulin (depending on how this is tolerated) and will take approximately 4 hours at these visits."

Trial Locations (1)

48109

University of Michigan, Ann Arbor

All Listed Sponsors
collaborator

American Heart Association

OTHER

lead

Robert Silbergleit

OTHER

NCT05062785 - Dose-Finding Study of Intranasal Insulin in Healthy Participants Insulin in Healthy Participants | Biotech Hunter | Biotech Hunter